SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-165965
Filing Date
2017-05-10
Accepted
2017-05-10 16:32:52
Documents
45
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d378627d10q.htm 10-Q 335138
2 EX-31.1 d378627dex311.htm EX-31.1 5979
3 EX-31.2 d378627dex312.htm EX-31.2 6246
4 EX-32 d378627dex32.htm EX-32 4899
  Complete submission text file 0001193125-17-165965.txt   2684458

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT itci-20170331.xml EX-101.INS 511476
6 XBRL TAXONOMY EXTENSION SCHEMA itci-20170331.xsd EX-101.SCH 28351
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itci-20170331_cal.xml EX-101.CAL 39522
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itci-20170331_def.xml EX-101.DEF 108958
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20170331_lab.xml EX-101.LAB 271693
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20170331_pre.xml EX-101.PRE 199929
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36274 | Film No.: 17830823
SIC: 2834 Pharmaceutical Preparations